Controlled Drugs and Accountable Officer
The spring 2025 edition of the NHSE Midlands CD Newsletter has now been published
Topics in this newsletter include:
- Midlands Controlled Drugs Accountable Officers
- Important Information
- News around Controlled Drugs:
- Collection by a representative of a drug misuse patient
- Significant Incident – Patient Return of Controlled Drugs
- Training video for Pharmacy Teams on the safe use of Fentanyl patches
- MHRA Drug Safety Update – Prolonged-release opioids: Removal of indication for relief of post-operative pain
- Guidance – Medicine choices in opioid substitution treatment
- The public health risks of counterfeit pills
- Revised Summary of Product Characteristics (SmPC): Lyrica (Pregabalin) Capsules
- Regulation 28 Notices
- Reminders
With effect from 1st August 2024, the NHS England Midlands Controlled Drugs Team will be using a single group (enquiries) e-mail account england.midlandscd@nhs.net
From 1 September 2024, the following arrangements will be in place for geographical CDAO cover
| West Midlands | East Midlands |
| Amit Dawda will be the CDAO for West Midlands and cover the following ICB areas: | Samantha Travis will be the CDAO for East Midlands and cover the following ICB areas: |
|
|
| Amit can be contacted on amit.dawda@nhs.net , or the West Midlands CD Team can be contacted via england.MidlandsCD@nhs.net | Sam can be contacted on Samantha.travis@nhs.net, or the East Midlands CD Team can be contacted via england.MidlandsCD@nhs.net |
Please could you share this newsletter with all relevant members of your team.
